that when concentrations of luteinising hormone are high throughout the follicular phase, as in some women with polycystic ovaries, the hormone penetrates the follicle and allows the oocyte to mature prematurely, resulting in ovulation of an oocyte that is physiologically "aged." Such oocytes are unlikely to be fertilised or will tend to produce embryos that implant poorly and therefore abort. Data that support this model were reported in studies of pigs in which premature ovulation (and presumably maturation of oocytes) was induced with human chorionic gonadotrophin'°and in studies of rats in which insemination was delayed." In both studies the interval between maturation of the oocytes and fertilisation was extended and rates of fertilisation and embryo survival were impaired. In women extension of the interval between ovulation and insemination was associated with a striking increase in the rate of miscarriage.'2 Moreover, Stanger and Yovitch, Howles et al, and Punnonen et al have reported that high concentrations of luteinising hormone in the few days before oocytes were collected from women for in vitro fertilisation were associated with impaired rates of fertilisation and conception.
Our results show that high concentrations of luteinising hormone during the follicular phase, found in many women with the polycystic ovary syndrome, have a deleterious effect on the success of induction of ovulation and conception and may be a causal factor in early pregnancy loss. As recent studies suggest that the polycystic ovary syndrome is common, both in patients attending infertility clinics and in the general population,"6 " many patients may perhaps experience early miscarriage because of an endocrine disturbance. A potential treatment for these patients is to induce ovulation with exogenous gonadotrophins after desensitisation of the pituitary with a superactive analogue of luteinising hormone releasing hormone.7 1 Armar NA, Adams J, Jacobs HS. Induction of ovulation with gonadotrophin releasing hormone. In: Bonnar J, ed. figure) . The degree of fetal smallness was expressed as the number of standard deviations by which the observed abdominal circumference differed from the normal mean for gestational age, and the severity ofhypoxia was expressed as the difference between the oxygen tension observed and the normal mean for gestational age.4 The correlation between the degree of fetal smallness and the pH ofblood from the umbilical vein (r= -0 -095) or the severity of fetal hypoxia (r= -0 02) was not significant. Seven fetuses had normal oxygen tensions and pH, 25 were hypoxic, five were acidotic, and 22 were both acidotic and hypoxic.
Comment
Increased impedance to blood flow in the umbilical artery, as shown by the absence offrequencies at the end of diastole, seems to be a good marker of fetal asphyxia. As all the patients in this study had been referred, and therefore preselected, we cannot comment on the prevalence of this marker in fetuses that are small for gestational age.
The absence of significant correlation between the degree of smallness of the fetus and hypoxia or acidosis shows that uteroplacental insufficiency is not the only cause ofsmall fetal size. Moreover, many babies that are growth retarded because ofuteroplacental insufficiency have birth weights that are within the normal range for gestational age.5 If waveforms of flow velocity in the umbilical artery prove to be as useful a marker of prenatal asphyxia in well grown fetuses as they are in small fetuses they may replace measurement offetal size for the antenatal prediction of fetal asphyxia. Missed diagnoses of fetal hypoxia might account for some "unexplained" stillbirths. -8-11-5) 4-9 (2*8-7 0) 59 (1 7-11 1) 4-3 (2 1-6-9)
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